Sight DiagnosticsⓇ is a blood diagnostic company that combines machine vision and AI to improve health through fast, convenient and accurate diagnostics. Developed over almost a decade of research, Sight’s technology combines the latest innovations in blood sample preparation, optics, chemistry, biology, physics and computer science.
Sight’s first product, Parasight™ *, has diagnosed malaria in nearly 1 million tests across 24 countries. Sight OLOⓇ, Sight’s latest blood analyzer, digitizes blood with only 2 drops of a finger prick or venous sample and provides lab-grade CBC results in minutes. Sight has growing offices in the UK, the US and Israel.
*Note: Parasight™ is not available for sale in the US and did not receive FDA clearance for use in the US.